@inproceedings{inproceedings, title  = {{Abstract P5-15-03:nab-paclitaxel + carboplatin or gemcitabine vs gemcitabine/carboplatin as first-line treatment for patients with triple-negative metastatic breast cancer: Results from the randomized phase 2 portion of the tnAcity trial}},

 publisher = {{American Association for Cancer Research}},

 url = {{}},

 year = {{2017}},

 month = {{2}},

 author = {{Yardley D and Coleman R and Conte P and Cortes J and Brufsky A and Shtivelband M and Young R and Bengala C and Ali H and Eakel J and Schneeweiss A et al}},

 doi = {{10.1158/1538-7445.sabcs16-p5-15-03}},

 journal = {{Poster Session Abstracts}},

 note = {{Accessed on 2025/10/10}}}